Trillium Asset Management LLC Invests $30.57 Million in Encompass Health Corporation $EHC

Trillium Asset Management LLC acquired a new stake in shares of Encompass Health Corporation (NYSE:EHC) in the 2nd quarter, HoldingsChannel.com reports. The firm acquired 302,395 shares of the company’s stock, valued at approximately $30,566,000. Encompass Health accounts for about 0.9% of Trillium Asset Management LLC’s investment portfolio, making the stock its 26th biggest position.

A number of other institutional investors have also recently made changes to their positions in EHC. BlackRock Inc. purchased a new stake in Encompass Health in the second quarter valued at about $1,059,762,000. Price T Rowe Associates Inc. MD grew its stake in shares of Encompass Health by 24.6% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 4,805,413 shares of the company’s stock worth $510,047,000 after acquiring an additional 948,202 shares during the last quarter. Northwestern Mutual Wealth Management Co. grew its stake in shares of Encompass Health by 3,059,159.7% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company’s stock worth $402,640,000 after acquiring an additional 3,793,358 shares during the last quarter. Wellington Management Group LLP increased its holdings in shares of Encompass Health by 21.7% during the fourth quarter. Wellington Management Group LLP now owns 3,384,877 shares of the company’s stock valued at $359,271,000 after acquiring an additional 603,472 shares in the last quarter. Finally, T. Rowe Price Investment Management Inc. raised its position in shares of Encompass Health by 27.2% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 2,722,887 shares of the company’s stock valued at $289,008,000 after purchasing an additional 581,812 shares during the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the stock. Leerink Partners set a $152.00 target price on shares of Encompass Health in a research note on Friday, May 22nd. TD Cowen raised their price target on shares of Encompass Health from $125.00 to $140.00 and gave the stock a “buy” rating in a report on Monday, August 10th. Barclays lifted their price objective on shares of Encompass Health from $140.00 to $144.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. Wall Street Zen raised shares of Encompass Health from a “hold” rating to a “buy” rating in a report on Sunday, August 16th. Finally, Weiss Ratings raised Encompass Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, August 12th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, Encompass Health presently has a consensus rating of “Buy” and an average price target of $148.71.

Insider Buying and Selling at Encompass Health

In other Encompass Health news, CEO Mark J. Tarr sold 173,148 shares of the stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $125.47, for a total transaction of $21,724,879.56. Following the sale, the chief executive officer directly owned 267,814 shares of the company’s stock, valued at approximately $33,602,622.58. This trade represents a 39.27% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP John Patrick Darby sold 8,906 shares of Encompass Health stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $125.95, for a total value of $1,121,710.70. Following the transaction, the executive vice president owned 75,041 shares of the company’s stock, valued at $9,451,413.95. The trade was a 10.61% decrease in their position. The disclosure for this sale is available in the SEC filing. Company insiders own 1.80% of the company’s stock.

Encompass Health Price Performance

Shares of NYSE EHC opened at $120.89 on Friday. The business’s 50 day moving average price is $110.63 and its 200 day moving average price is $106.29. The firm has a market cap of $11.93 billion, a P/E ratio of 19.69, a P/E/G ratio of 2.47 and a beta of 0.72. Encompass Health Corporation has a 52 week low of $92.77 and a 52 week high of $127.99. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Wednesday, August 5th. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.48 by $0.07. Encompass Health had a net margin of 10.01% and a return on equity of 18.08%. The company had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.57 billion. During the same period last year, the firm posted $1.40 EPS. Encompass Health’s revenue for the quarter was up 9.6% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. On average, sell-side analysts expect that Encompass Health Corporation will post 6.08 earnings per share for the current year.

Encompass Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be issued a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a dividend yield of 0.7%. This is a boost from Encompass Health’s previous quarterly dividend of $0.19. The ex-dividend date of this dividend is Thursday, October 1st. Encompass Health’s dividend payout ratio is 12.38%.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.